Direct and Indirect Inhibition Effects of Resveratrol against Toxoplasma gondii Tachyzoites In Vitro
Authors:
- 1 March 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (3)
Abstract
Toxoplasma gondii is one of the most widespread obligatory parasitic protozoa which infect nearly all the warm-blooded animals, leading to toxoplasmosis. Current administration of the therapeutic drugs like the combination of pyrimethamine and sulfadiazine shows high rates of toxic side effects and encounters drug resistance in some cases. Resveratrol is a natural plant extracts with multiple functions, such as anti-bacterial, anti-cancer and anti-parasite activities. In this study, we evaluated the inhibitory effects of resveratrol upon the tachyzoites of Toxoplasma gondii RH strain extracellularly and intracellularly. We demonstrated that resveratrol possessed a direct anti-toxoplasma activity by reducing the population of extracellularly grown tachyzoites, probably through disturbing the redox homeostasis of the parasites. Moreover, resveratrol was also able to release the burden of cellular stress, promote the apoptosis and maintain the autophagic status of macrophages that were turned out to be regulated by intracellular parasites, thereby functioning indirectly in eliminating T. gondii. In conclusion, resveratrol has both direct and indirect anti-toxoplasma effects against the RH tachyzoites and may possess a potential to be further evaluated and employed in toxoplasmosis treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81672048)
- National Natural Science Foundation of China (81186307)
- National Natural Science Foundation of China (31572240)
- National Natural Science Foundation of China (31872959)
This publication has 48 references indexed in Scilit:
- Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosisProceedings of the National Academy of Sciences, 2012
- Superoxide dismutases: Ancient enzymes and new insightsFEBS Letters, 2011
- Temporal and Spatial Distribution of Toxoplasma gondii Differentiation into Bradyzoites and Tissue Cyst Formation In VivoInfection and Immunity, 2008
- Resveratrol: One molecule, many targetsIUBMB Life, 2008
- Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the familyEMBO Reports, 2006
- Reactivation of Toxoplasma Retinochoroiditis Under Atovaquone Therapy in an Immunocompetent PatientOcular Immunology and Inflammation, 2006
- Calcium and a Calcium-Dependent Protein Kinase Regulate Gamete Formation and Mosquito Transmission in a Malaria ParasiteCell, 2004
- The Molecular Basis of Sulfonamide Resistance inToxoplasma gondiiand Implications for the Clinical Management of ToxoplasmosisThe Journal of Infectious Diseases, 2002
- Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 StudyClinical Infectious Diseases, 2002
- Toxoplasmosis of the Central Nervous System in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1992